I have studied the action of various drugs injected into the cerebral lateral ventricle of the conscious cat'. For this purpose we screwed a metal cannula into the skull and kept it permanently in position sometimes for more than a year, without apparently producing any ill-effects. The tip of the cannula rested in the lateral ventricle; the butt, outside the skull, was closed by a cap with a rubber diaphragm through which the injections were made.
produced a condition resembling light nembutal aneesthesia. A similar effect had previously been described, by Leimdorfer in America, on cisternal injection of larger doses of these amines.
These changes produced by the anticholinesterases, adrenaline and noradrenaline, are changes of depression or impairment of consciousness or awareness, and it is interesting that this region which we flood pharmacologically is generally associated with consciousness. For instance, electric stimulation of certain points immediately under the surface of the third ventricle, i.e. the massa intermedia, produces sleep, as shown by Hess. Further, it is well known that tumours pressing on this region cause unconsciousness in man. Atropine, on the other hand, produced increased liveliness but with signs that the cat's appraisal of its surroundings was impaired.
With a number of drugs injected intraventricularly, the motor phenomena were predominant. Sherwood and I found that hexamethonium and histamine produced muscular weakness; Banthine, muscular inco-ordination; decamethonium, spastic paralysis; and +tubocurarine, in an amount of as little as 30 jig., general convulsions resembling major epileptic fits, during which the animals were apparently unconscious. The +tubocurarine convulsions are of particular interest to the theory of subcortical origin of epileptic seizures, because of the ability to simulate seizure-like activity by drugs acting from subcortical regions.
The finding that the anticholinesterases when injected intraventricularly into cats produce signs of severe itching is relevant to the phenomenon of itching in general. It is interesting to recall that cats may act in a similar way on electrical stimulation of certain structures of the mid-brain. Hess found that cats acted in this way on stimulation of the nuclei of the septum pellucidum as far ventral as the anterior commissure and in a region immediately above and behind the mammillary bodies, i.e. structures bathed by the ventricular fluid.
When discussing the physiology of itching we have thus to distinguish between itching originating in the skin and itching of central origin. The main physiological stimulus for itching in the skin may well be the release of histamine in the skin, and it is therefore not surprising that itching is a well-known feature of the effects of histamine liberators in man. It will not always be easy to assess whether the itching produced by administration of a drug is a central or a peripheral effect. Morphine, for instance, is a histamine liberator but also causes signs of itching on cisternal injection. Therefore the well-known pruritus in man after administration of morphine may in some cases be of peripheral origin, in others of central, and again in others a combination of both mechanisms. There are other clinical observations of itching which are unlikely to be due to primary skin conditions and where the itching is central in origin, for instance the itching of lichen planus, since it is so dramatically relieved by lumbar puncture and removal of a few ml. of cerebrospinal fluid.
Stupor and catatonia appear to be characterisitic features of the presence of acetylcholine and anticholinesterases in the ventricular system. Since catatonia occurs in some forms of schizophrenia it is interesting to note that other attributes characteristic of this mental disease have been described in response to anticholinesterases. DFP was tried in America by Grob, Lilienthal and Harvey, and in England by Rowntree, Nevin and Wilson, in the treatment of myasthenia gravis, but the patients refused the continuation of daily intramuscular injections of DFP because they led to insomnia, nightmares, mental confusion, and hallucination. In addition, Rowntree et al. found that DFP produced in a number of schizophrenic patients an activation of the psychosis or the reappearance in chronic cases of the florid symptoms which had characterized the onset of the illness. If we assume that the catatonia produced on intraventricular injection of anticholinesterase is the result of cholinergic neuronal activity or excess of acetylcholine in the region of the periventricular grey-and it is difficult to avoid this conclusion-then it may well be that the hallucinatory and other phenomena seen in patients after DFP are also due to its cholinesterase inhibiting effect in the mid-brain.
Several drugs are known to produce catatonia in animals on subcutaneous injection. The best-known drug of this kind is bulbocapnine. Sherwood and I found that on intraventricular injection in cats it brings about a state of catatonia in doses a fraction of those required to produce this effect by subcutaneous administration. The relative smallness of dosage and the speed with which the bulbocapnine effects appear with this route of administration seem to indicate that structures close to or directly in contact with the ventricular surface are likely to be implicated. This indication is borne out by comparison with results obtained by lesions of selected anatomical sites in the mid-brain close to the ventricular lining. From these, and only from these sites, catatonic effects analogous to those of bulbocapnine are obtained, as shown by Ingram, Barris and Ransom, by Bailey, by Magoun, by McCulloch, Ridley and Sherwood, and by Hess. Further, in doses (100-200 ,ug.) even smaller than those needed to produce consistently signs of catatonia, bulbocapnine caused changes in behaviour or "character" of the animal which lasted for about half an hour. A previously friendly and affectionate cat, when approached in this condition, lashed its tail, tried to bite, hit out with one or both front paws, sitting erect and hissing with bared teeth. Thus, a striking although short-lasting change in behaviour occurred in response to a drug which again probably acted on the periventricular grey matter.
In animals, the main method of obtaining the syndrome of catatonia, apart from drugs, is the placing of lesions in the upper brain-stem. This raises the question of whether the drugs bulbocapnine, the anticholinesterases, and acetylcholine also produce a kind of pharmacological lesion by paralysing nerve cells and thereby interrupting some specific pathways, in analogy to the paralysing effects of acetylcholine (or nicotine) on peripheral structures when producing block of synaptic transmission in a sympathetic ganglion, or neuromuscular block.
Finally, when discussing the action of adrenaline and noradrenaline in producing a condition resembling light Nembutal anesthesia, we have to realize that noradrenaline is a normal constituent of the central nervous system. Vogt has recently mapped out its distribution in the dog's brain. Highest concentrations were found in the diencephalon, the mesencephalon, and the medulla oblongata; in fact, in those regions of the brain on which the noradrenaline probably acts when producing the condition resembling light anesthesia. The region mapped out by Vogt for high concentration of noradrenaline closely resembles Magoun and Jasper's arousal area in the reticular formation in the brain-stem, and this naturally raises the question of whether noradrenaline normally influences our state of awareness by being released in this region. From its distribution in the brain and its central action one is, in fact, tempted to postulate for noradrenaline an important central function, that of exerting an influence within the reticular activating system. Noradrenaline may not be the only substance acting in this way; other pharmacologically active substances present in this region-for instance, Amin, Crawford and Gaddum have shown that the distribution of 5-hydroxytryptamine in the brain follows fairly closely that of noradrenaline-may act on or through this system. Several of the effects Sherwood and I observed on intraventricular injection, on the sensorium as well as on the motor side, may finally find their interpretation on these lines.
In conclusion I want to stress that the gap we are trying to span between pharmacology of the central nervous system and mental disorders is still one which has to be crossed with the utmost caution: there are danger signs facing us at almost every step.
Dr. S. L. Sherwood (National Institute for Medical Research and Severalls Hospital, Colchester, Essex):
The Response ofPsychotic Patients to Intraventricular Injections An attempt was begun five years ago to treat chronic catatonic stupor by intraventricular injection of drugs. The reasons for employing this particular method and its early results have been described in Brain (Sherwood, 1952) .
The particular methods of observation and recording employed were selected with the hope of discovering the influence of treatment on the patients' particular signs, symptoms and disabilities; for this reason patients with unequivocal syndromes were selected in the first place and a number of relevant tests and observations in the field of pathophysiology had to be sacrificed for lack of facilities and man-power.
In all 26 patients had intraventricular injections (5 of these were treated at Manteno State Hospital, Illinois). In the early cases the injections were given with sharpneedles through the scalp and previously made frontal burr holes; more recently this was done with fine hypodermic needles through the scalp and rubber-bung of a cannula screwed into the frontal bone; with either method the frontal horn of the ventricles ..........was reached (Fig. 1 ). .......................... Early on, distilled water was used as a vehicle, later saline, and recently Tyrode's solution which contains a pH-buffe6t system; distilled water itself has an effect on the patient of shock which may last several hours. The volume injected varied from 1 to 10 ml., and in the case of saline, or Tyrode's solution, appears to have no effect of its own, provided the intraventricular pressure is not The initial drug doses were calculated as that proportion of the systemic dose which would be contained in the ventricular fluid if the distribution after systemic injection were even throughout the body.
All cases treated in this series were chronic psychotics. In the Severalls Hospital series the illness had lasted between three and twenty-five years-average 10:7 years.-The ages, diagnoses and duration of illness in all cases are displayed in Tables I and II; the Tables   also show where surgical treatment has been carried out.  TABLE I Tables I and II, representing a summary of all the cases treated. It will be noted that with three exceptions all patients did show improvement and that the performance of a leucotomy, either before or after a course of injection:treatment, had no decisive effect on the result of injection treatment.
The injections were spaced at daily to fortnightly intervals according to persistence of effects and the patient's needs. In all 366 injections have been given; the largest number in any one case was 59 injections, and the smallest number 3. All except 3 patients had more than one drug, given at different times. In several cases control injections of distilled water, saline and Tyrode's solution were given with no clear-cut effect; the difference in drug effects themselves provided further satisfactory proof of the causation of the changes.
During the last two years all cases were controlled and followed up with extensive EEG recordings.
I shall now report the effects of the individual drugs, first stating the immediate effect and, second, the long-term effects.
Adrenaline HCI. 5 patients received this drug. 4 were chronic catatonics, one was a case of familial myoclonic epilepsy. The effects when given intracisternally in doses of 05-2 mg. have been described by Leimdorfer (1950) and by Leimdorfer and Metzner (1949) in non-psychotic patients and animals and for noradrenaline by Feldberg and Sherwood (1954) given to cats intraventricularly, as those resembling sleep or anesthesia.
In the present series 4 patients received 2 to 4 successive injections of adrenaline HCI in doses from 5-250 ,ug. dissolved in 1 to 5 ml. saline or, in one case, Tyrode's solution. In all four cases, and with all doses tried, adrenaline produced a general relaxation and lowering of muscle tone, but no apparent weakness; this was associated with a transient flush of the face and warming of the limbs; later, especially with higher doses, the patient may sweat and his face may become pale, although his skin remains warm. Nausea and vomiting occurred in 3 patients who received the drug in saline; of the other two, one, a catatonic of over twenty years' standing and showing advanced deterioration, showed little sensitivity to cholinesterase also, and the other-the case of familial myoclonus-received his injection in Tyrode's solution, i.e. the acid drug in a buffered solution.
Within ten to thirty minutes, depending on the dosage, all patients became drowsy and dozed or slept; they were all easily aroused; the previously inaccessible schizophrenics showed understanding by answering simple questions rationally, with the one exception just mentioned; before they became drowsy they would utter short remarks spontaneously and appropriately. This stage was brief and usually too short to explore the possibilities of a lengthy conversation. This stage of drowsiness began to wear off after fifty minutes with the smaller and after two to three hours with the larger doses; a gradual reappearance of the previous signs and symptoms occurred over the next twelve hours; for the next day or two the patients were a little more active, showing less rigidity in their behaviour patterns but they were also more liable to obey sudden or violent impulses. 95after 2imi Adren HCI O1g. 145 The patient suffering from familial myoclonic epilepsy (von lJnverricht's disease) reacted similarly but he was a much better witness: he became sleepy only after forty to fifty minutes, some twenty minutes after the EEG had begun to show features associated with sleep. Five minutes after the injection, on three occasions, he fancied he had passed urine-but this was in fact not so; he also experienced slight transient nausea with 50 ,ug. of adrenaline, and none with 15: in either case the spasms and twitches were absent or markedly reduced, and he was less spastic for two to three days.
In the case of the schizophrenics the EEG showed the following changes: if there was no alpha rhythm in the control record, a regular rhythm appeared within 30 seconds to a few minutes (Fig. -2) . When an alpha rhythm had been present before injection, it was greatly enhanced, and in either case, after a transient increase in frequency during the first few minutes, it dropped to a lower rate. At the height of the drug effect the records were very similar to a typical light sleep record, particularly one obtained with the aid of barbiturates. In the case of familial myoclonic epilepsy, there was a great reduction of spikes and irregular slow waves and also, of course, of the twitch artefacts (Fig. 3) . Banthine and Probanthine.-This drug (P-diethylaminoethyl xanthene-9-carboxylate methobromide) has, in addition to an atropine-like effect, a blocking action on autonomic ganglia, and in large doses on the neuromuscular junction. 11 patients received this drug in up to 19 successive injections; 9 were catatonic schizophrenics, one a well-preserved paranoid schizophrenic and one a simple schizophrenic. Within about one hour of each injection all patients became more active: this concerned both "spontaneous" behaviour, and reactions; with larger doses-500 ,g. or more-catatonic patients would become overactive and show emotional stress, especially patients who were hallucinated or under the influence of harassing delusions, so that they displayed impulsive and sometimes even violent outbursts; some became very agitated by them and injections of Banthine were discontinued; most of them became capable of expressing themselves and of describing their state well-especially those with paranoid trends; even those who spoke only gibberish became garrulous. During a course of injections at weekly intervals for five to ten weeks it appeared that some patients who suffered from delusions and hallucinations became conscious of the abnormality of their experiences, but did not lose them: their affective capacity was more influenced than their thought processes. The effect of a single Banthine injection persisted for up to one week; some patients showed a general improvement after the end of a course of injections which far exceeded their state before treatment, and this improvement endured for up to four or six weeks after the last injection-especially in those who before treatment were little disturbed by their hallucinations or delusions. The only consistent physical signs were a general improvement of complexion and, with doses of 500-1,000 ,ug., slight muscular weakness for two to three hours after injection.
The EEG again showed a change in the number of alpha frequencies if several had been present before-usually an intermediate or slightly faster one became more prominent; rhythms of the beta range increased and became clearer and complexes within the delta range also became prominent for the first few hours after each injection (Fig. 4) .
Cholinesterase.-This enzyme, which hydrolyses acetylcholine, is difficult to obtain and purify. Originally freeze-dried human erythrocyte stroma was used; later an extract of the electric organ of electric eel was used. One ml. of this was capable of hydrolysing 4 grams of acetylcholine per hour; latterly a preparation from human erythrocytes in which the active fraction had been detached from the stroma and thus become water soluble, was used; it had a Q ACh. of 126. 15 schizophrenics received between 1 and 32 injections of cholinesterase.
The earlier preparations had undesirable immediate results; they causeda good deal of nausea and vomiting and a fall in blood pressure; the electric eel preparation was better than this although less efficient also on the state of the psychosis with the passage of time; the most recent preparations freshly made up from dry powder in Tyrode's solution instead of saline or distilled water produced few or none of these signs; a slight sensation of nausea was easily counteracted by 3-5 grains of Chloretone given half an hour before the injection.
The effect of cholinesterase became noticeable within the first minute after injection; the patient becomes flushed and increasingly accessible; fully catatonic patients begin to react and within one to three hours they respond to instructions or reply to simple questions; they may eat and look after their own needs. One patient, in a perpetual state of violent paranoid excitement and confusion, calmed down within two hours and became co-operative and spoke rationally. This clinical general improvement may continue from one to three weeks after a single injection, especially if larger doses are used; usually injections were given at about weekly intervals. Of the 15 patients treated 6 improved at one time or other to behaviour approaching normal, and this persisted for four years in one case, and for two years in another without further injections. However, both these patients had had a leucotomy one and two years respectively before injection treatment; in others the improvement would not outlast the last injection by more than four weeks. Only 2 patients showed no certain improvement. All others became more, if not fully, reasonable and co-operative and alert. 2 became depressed, agitated and tearful-possibly because of their increased alertness and insight-and it was thought wiser and kinder to discontinue injections and proceed to leucotomy, especially since the supply of cholinesterase was insecure at the time.
In the EEGs, the alpha rhythm was greatly enhanced and stabilized at a frequency usually higher than the lowest previously shown; only in one case, with an original rhythm at 12 c/s, was there a drop. The higher rhythms of the beta range tended to slow down and lose amplitude and tended to disappear in the favourable cases. Complexes or delta rhythms appeared rarely following cholinesterase injections (Fig. 5) .
Pentamethonium Iodide, a myoneural blocking agent, had an effect similar to cholinesterase but less marked and never enduring for more than twelve to thirty-six hours; nausea was absent; Flaxedil also resembled this kind of action. The doses used were 150 and 300 ,ug. respectively per injection. Hyaluronidase was given in 5 cases in saline by itself and in 8 cases combined with other drugs (cholinesterase, C5, Flaxedil) on the speculation that tissue permeability might be improved; no definite conclusions were obtained. The doses used were 300-500 ,ug.
Sdey
Serotonin. The neurotropic effects of this drug have been described by Woolley and Shaw (1954) and Amin et al. (1954) who showed that it is a potent antagonist to lysergic acid diethylamide and that the mid-brain naturally contains 5-hydroxytryptamine. 4 patients received this drug in doses of 15 to 75 ,ug. Within a few minutes of the injection the patients begin to yawn and clear their throats with increasing vigour and loudness; after an early flush the patients become pale and perspire; one patient vomited without nausea; the pulse-rate tends to drop; gradually, over the next one to three hours they become more active or even restless; they talk readily and make contact easily although there is no early effect on their thought processes; one patient sang and shouted for many hours; nevertheless there was no evidence of distress. Over a period of weeks of two to three weekly injections they improve stepwise until they become employable and interested; personal habits improve also, they feed themselves more tidily, look after their personal toilet, their speech assumes increasing relevance, and they can spend their time to some extent as part of a community. The case of paranoid schizophrenia improved so much after 5 injections-the delusions appeared to have gone-that she was able to leave the hospital for home; however, she had had a modified leucotomy some eighteen months earlier and had never shown any degradation; she remained at home some three months before she had to return. Treatment of 2 cases of dementia prncox had to be broken off-one because of a flare-up of phthisis and the other becautse of a C.S.F. infection. The case of catatonic schizophrenia has continued to be very well for two months after the last injection. In fact, the most striking improvement occurs early during a course of injections and after the end of it.
The EEG shows an increase of alpha amplitude but not frequency and a stabilization of the frequency with clinical improvement. There is, however, especially during the period of transition and improvement, also a transient increase of delta waves and abnormal complexes; fast rhythms tend to disappear (Fig. 6 ).
There are some features that are-as in the animal experiments-common to all drugs used in this series: they include the changes in complexion which persist much longer than the mental changes after the drug; within the first few hours there may be nausea or vomiting, a drop in blood pressure, and during the first twenty-four to thirty-six hours there is often- especially with cholinesterase-a rise in temperature which is not due to an infection. In general also, the C.S.F. pressure is related to the patient's mental health: it is low-often not exceeding atmospheric pressure in catatonics in the prone position-and it rises with improvement to normal levels of about 10 cm. of C.S.F. above the skull surface. Some women with amenorrhoea began to menstruate again.
Complications.-4 of the patients had epileptic seizures, but each time evidently the choroid plexus or a branch of the anterior cerebral artery had been punctured, for bloodstained fluid was aspirated: no fits ever occurred when the C.S.F. was clear.
Infections of the C.S.F. occurred in 3 cases-they were discovered through routine C.S.F. examination and were due in all cases to so-called non-pathogenic organisms. There was no difficulty in controlling the infections with antibiotics. None of the patients showed signs of ventriculitis or meningitis. Some of the cannulh were removed for this reason; in other cases the cannule had to be reinserted because they were blocked by a gelatinous substance-especially in the earlier narrow-bore model.
On the whole, of the drugs most extensively tried, cholinesterase had the most marked effect on abnormal thought processes and hallucinations, Banthine greatly increased activity but reactions did not necessarily become more adequate to stimuli themselves; Serotonin has also a marked effect on activity and reactivity, though perhaps a slightly less marked effect on the quality of reactions. It appears to stand between cholinesterase and Banthine.
In the EEG records, there are some specific trends regarding the various frequencies usually displayed by patients within the schizophrenic group; it is, however, clear that well-being in any one patient is associated with a certain alpha frequency and a certain pattern of distribution of this rhythm; the recurrence, after discontinuation of injections, of the earlier pathological pattern goes stepwise with the state of the patient's mind. Thus, the EEG changes are specific both for the patient and the drug (Tables III, IV, V) .
The method of intraventricular medication has not yet been used on recent or mild cases and on very few cases only who could describe well the sensations experienced on receiving an intraventricular injection.
The dosage of each injection and the spacing of them still represents serious difficulties; in the light of the Banthine injections, there can be no doubt that an overshooting of the ,33 861 goal can occur; on the other hand, in the case of cholinesterase it happened twice that patients after a period of marked improvement and without further injections relapsed, going through a state of "oneirophrenia" in which further injections became technically impossible.
Two patients showed so little response to intraventricular injection of any drug that further injections were abandoned. One was a case of catatonic stupor in a woman aged Tables III, IV, and V, illustrating relationship between EEG and mental state. Note alpha frequency. 43 which had persisted for sixteen years. The other was a grossly deteriorated case of dementia prmcox of ten years' duration (see Tables I and II ).
The different effects of various drugs administered through the ventricles make it difficult, if not impossible, to deny that the results obtained must be based on a selective sensitivity of ependymal areas to different drugs. That the areas so greatly influencing behaviour should be accessible by this method is not surprising if one considers that Hess was able to obtain with electrical stimulation in cats integrated behaviour patterns in areas which are very close to the ventricular surface near the mid-line. It is especially the posterior subthalamic areas from which he has been able to obtain behaviour that included anger, aggression, irritability, mood swings and even movements which make it difficult to assume that they are caused by anything but a hallucination. Whether the primary lesion in the schizophrenic is a "lesion" or not, it is difficult to decide: we know, further, from the EEG and from recordings made from the mid-brain of cats which were made "catatonic" by lesions, that there are areas which are electrically hyperactive and not subject to modifications by external stimuli. It would be an attractive theory to assume that this hyperactivity is the result of "de-afferentation" from their normal sources, for it has been possible to compensate with cholinesterase to some extent for the effect of lesions in cats. On the other hand, exacerbation of signs can be brought about with acetylcholine (Sherwood et al., 1952) in the ventricles or by systemic or intraventricular bulbocapnine (Ingram and Ranson, 1934; Feldberg and Sherwood, 1955) . Recent work in which labelled isotopes were used (Sweet and Locksley, 1953; Roy John, 1954) has shown that the various constituents of the C.S.F. are produced and reabsorb!d at diffierential rates and, moreover, that these rates may vary with the state of the animal. This information, together with the implications of selective sensitivity of certain cell groups, makes intraventricular injections a suitable tool for investigation and treatment in mental disorders.
In no two patients are exactly the same functions impaired. Indeed, mental illness often represents a picture of partial disorders. While, for instance, logical thinking as we know it may be absent the patient is still able to perform the majority of ordinary functions perfectly. In fact, any one set of functions may be picked out by the illness and disordered. Since definite behaviour patterns have been produced in animals by the action of drugs, it may be possible to counteract the malfunction of these by employing the appropriate drug locally.
Dr. D. Richter: Though intraventricular injection is not in itself new, Dr. Feldberg and Dr. Sherwood, by their use of permanently implanted cannule, have made observation very much easier, and the systematic study of a series of drugs in this way represents a considerable advance.
This work has opened up a big new field for research. The effects of the drugs examined have so far been given mainly in qualitative terms, and there is clearly room for further quantitative experiments. This applies not only to measurements of metabolic factors and the electrical activity of the brain, but also to measurements of behavioural changes of the kind that can be made by a psychologist. It would be of interest, for example, to measure the effects of drugs administered in this way on the behaviour of experimental animals in conditioning experiments, and the effects on trained animals studied by a maze technique.
The number of different drugs available for study is enormous. Those chosen for investigation must therefore be chosen with some care. Of obvious interest are the so-called "fantastica", which act primarily on the higher centres of the brain. But more may perhaps be learned by studying the effects of specific metabolic factors such as enzyme inhibitors. In this way we may be able to learn more about the significance of the different biochemical processes going on in vivo in the brain. A few years ago it was commonly believed that the metabolism of any one part of the brain was much the same as that of another: only recently has it come to be recognized that different anatomical regions are specialized metabolically as well as in their physiological function. Biochemical differences in regions such as the substantia nigra and the red nucleus were suggested by the difference in colour; but more exact studies of the distribution of acetylcholine, cholinesterase, noradrenaline and other substances have. shown that there are large and important differences in the metabolism of different parts of the brain. By the use of specific metabolic factors much might therefore be learned.
Apart from the new knowledge gained by this work, it raises also the hope that it might lead to the development of new and more rational forms of treatment. Lindsay (1950) reported a method of treatment by injecting drugs into the frontal lobes of patients, and relevant in this connexion is some work of Tower's (1955) , who has recently shown that certain epileptic patients have a biochemical brain lesion, which can be remedied by biochemical methods of treatment. It would seem that something might be gained from a wider collaboration between the physiologists, neurosurgeons and biochemists in studying the effects of intracranially administered drugs.
